172 related articles for article (PubMed ID: 17017200)
1. Fundus autofluorescence before and after photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration.
Framme C; Bunse A; Sofroni R; Thalhammer T; Walter A; Sachs HG; Gabel VP
Ophthalmic Surg Lasers Imaging; 2006; 37(5):406-14. PubMed ID: 17017200
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
[TBL] [Abstract][Full Text] [Related]
4. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
5. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
Hamon F; Goeminne P
Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
Ladd BS; Solomon SD; Bressler NM; Bressler SB
Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
[TBL] [Abstract][Full Text] [Related]
11. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
Nicolò M; Ghiglione D; Lai S; Nasciuti F; Cicinelli S; Calabria G
Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.
Verteporfin Roundtable Participants
Retina; 2005; 25(2):119-34. PubMed ID: 15689800
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.
; ;
Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872
[TBL] [Abstract][Full Text] [Related]
15. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
Parodi MB; Da Pozzo S; Ravalico G
Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with verteporfin in Belgian patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Mori R; Kelkar A; De Laey JJ
Bull Soc Belge Ophtalmol; 2006; (299):57-64. PubMed ID: 16681088
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for age-related macular degeneration.
Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
[TBL] [Abstract][Full Text] [Related]
18. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
[TBL] [Abstract][Full Text] [Related]
19. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
Brown DM; Michels M; Kaiser PK; Heier JS; Sy JP; Ianchulev T;
Ophthalmology; 2009 Jan; 116(1):57-65.e5. PubMed ID: 19118696
[TBL] [Abstract][Full Text] [Related]
20. Sequence of early vascular events after photodynamic therapy.
Michels S; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
